tamoxifen
Astrazeneca
['ovarian']
#asco22 asstra trial looking at adding 2 yrs ovarian suppression (os) to tamoxifen for women that remained premeno after chemo. via dr. ps: 2-3 yrs a reasonable option, esp for women with diff tolerating it or at risk for cardiovasc. 
Translational Medical Oncologist (Biomarkers, Toxicities, Health Outcomes, Clinico-Genomic Big Data) @OncoAlert. Motto: "Let's make a difference". Views mine.